LEONOR ALVARADO: Open Payments
NPI 1598507089 · GARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 14 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $14 · 2025 $283
Food & beverage: $283
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 2 | $44 |
| PFIZER INC. | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Dexcom, Inc. | 1 | $31 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $18 |
| Ascensia Diabetes Care Us Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
| Dynavax Technologies Corporation | 1 | $15 |
Products named: GEMTESA, PREVNAR 20, Kerendia, Dexcom G6 Transmitter, Auvelity, JARDIANCE, Rybelsus, Veozah.
Industry payments across TX — which companies pay providers there.
